4.7 Article

SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity

期刊

JOURNAL OF PHARMACEUTICAL ANALYSIS
卷 13, 期 2, 页码 170-186

出版社

ELSEVIER
DOI: 10.1016/j.jpha.2022.11.010

关键词

Myocardial infarction; SUMO1; SnRNA-seq; Cardiomyocyte

向作者/读者索取更多资源

SUMOylation is a dynamic post-translational modification that maintains cardiac function and protects against hypertrophic response in the heart. The role of SUMO1 in myocardial infarction (MI) and the molecular details of heart cell responses to SUMO1 deficiency were investigated in this study. SUMO1 knockout worsened systolic dysfunction and infarct size after myocardial injury, and its loss promoted proliferation of endothelial cell subsets with angiogenic potential.
Small ubiquitin-related modifier (SUMOylation) is a dynamic post-translational modification that maintains cardiac function and can protect against a hypertrophic response to cardiac pressure overload. However, the function of SUMOylation after myocardial infarction (MI) and the molecular details of heart cell responses to SUMO1 deficiency have not been determined. In this study, we demonstrated that SUMO1 protein was inconsistently abundant in different cell types and heart regions after MI. However, SUMO1 knockout significantly exacerbated systolic dysfunction and infarct size after myocardial injury. Single-nucleus RNA sequencing revealed the differential role of SUMO1 in regulating heart cells. Among cardiomyocytes, SUMO1 deletion increased the Nppa thorn Nppb thorn Ankrd1 thorn cardiomyocyte subcluster pro-portion after MI. In addition, the conversion of fibroblasts to myofibroblasts subclusters was inhibited in SUMO1 knockout mice. Importantly, SUMO1 loss promoted proliferation of endothelial cell subsets with the ability to reconstitute neovascularization and expressed angiogenesis-related genes. Computational analysis of ligand/receptor interactions suggested putative pathways that mediate cardiomyocytes to endothelial cell communication in the myocardium. Mice preinjected with cardiomyocyte-specific AAV-SUMO1, but not the endothelial cell-specific form, and exhibited ameliorated cardiac remodeling following MI. Collectively, our results identified the role of SUMO1 in cardiomyocytes, fibroblasts, and endothelial cells after MI. These findings provide new insights into SUMO1 involvement in the patho-genesis of MI and reveal novel therapeutic targets.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据